What question did this study set out to answer?

To evaluate the impact of maternal cardiac disease and digoxin therapy on duration of pregnancy, labour length, birth weight percentile, and neonatal condition.

February 1, 1980Australian and New Zealand Journal of Obstetrics and Gynaecology

The Effect of Maternal Cardiac Disease and Digoxin Administration on Labour, Fetal Weight and Maturity at Birth

View Full Paper

Ask AI

Bookmark

Why the study?

Does maternal cardiac disease or digoxin administration affect the duration of pregnancy, labour, birth weight, or Apgar score?

Population

372 pregnant women (122 with cardiac disease, 250 controls)

Comparison

Maternal cardiac disease and digoxin… vs Pregnant women without cardiac disease (controls)

Design

Cohort

Authors

PHPak‐Cheong HoPrince of Wales Hospital TCT. Y. ChenUniversity of Hong Kong VWVivian WongHospital Authority

Discussion

Member takes

Implication

May support closer fetal growth monitoring in maternal cardiac disease; leaves open digoxin effects pending prospective confirmation.

Key Points

To evaluate the impact of maternal cardiac disease and digoxin therapy on duration of pregnancy, labour length, birth weight percentile, and neonatal condition.
Comparative study evaluating 122 pregnant patients with cardiac disease against 250 control patients.
Assessed gestational age at delivery, duration of labour, birth weight percentiles, and Apgar scores in relation to maternal disease severity and digoxin therapy.
Infants born to mothers with cardiac disease were frequently light-for-dates, with 18% scoring below the 10th birth weight percentile.
Multiparous patients with cardiac disease delivered at an earlier gestational age, but duration of labour did not significantly differ between cardiac patients and controls.
Neither digoxin administration nor heart disease severity showed a significant effect on gestational age, labour duration, or birth weight percentiles.

Structured PICO

Does maternal cardiac disease or digoxin administration affect the duration of pregnancy, labour, birth weight, or Apgar score?

Population

372 pregnant women (122 with cardiac disease, 250 controls)

Intervention

Maternal cardiac disease and digoxin administration

Comparator

Pregnant women without cardiac disease (controls)

Outcome

Duration of pregnancy and labour, birth weight percentile, and Apgar scorehard clinical

Maternal cardiac disease is associated with lower birth weights and earlier delivery in multiparous women, whereas digoxin use does not significantly impact these perinatal outcomes.

Cite This Study

Ho et al. (1980) studied this question.

synapsesocial.com/papers/6a919a63e771dc7bc3340f9b https://doi.org/10.1111/j.1479-828x.1980.tb00890.x

Topics

Congenital heart disease adults

View Full Paper

Ask AI

Bookmark

The Effect of Maternal Cardiac Disease and Digoxin Administration on Labour, Fetal Weight and Maturity at Birth

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

The Effect of Maternal Cardiac Disease and Digoxin Administration on Labour, Fetal Weight and Maturity at Birth

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider